ACAT Inhibition on the Progression of Coronary Atherosclerosis - ACTIVATE

Description:

The goal of the trial was to evaluate treatment with pactimibe, a novel enzyme acyl-coenzymeA:cholesterol transferase (ACAT) inhibitor, compared with placebo on change in atheroma volume among patients with symptomatic coronary artery disease.